ArticleCancers2023

Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing.

Konstantinos Agiannitopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.